Left Atrial Strain Prediction of New-Onset Atrial Fibrillation in Apical Hypertrophic Cardiomyopathy with Cardiac MRI

Yipei Song1,2, Mengyao Hu1,2, Tian Zheng1,2

  • 1Department of Radiology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Minde Road No. 1, Nanchang 330006, China.

Insights

Cardiac MRI-derived left atrial strain (LAS) predicts new-onset atrial fibrillation (AF) in apical hypertrophic cardiomyopathy (AHCM). LAS offers incremental prognostic value beyond standard measures for predicting AF development.

Area of Science:

  • Cardiology
  • Medical Imaging

Background:

  • Apical hypertrophic cardiomyopathy (AHCM) is a condition affecting heart muscle.
  • Atrial fibrillation (AF) is a common complication in AHCM.
  • Predictive markers for AF in AHCM are crucial for patient management.

Purpose of the Study:

  • To assess the predictive capability of cardiac magnetic resonance imaging (MRI)-derived left atrial strain (LAS) for new-onset AF in patients with AHCM.
  • To determine if LAS provides additional prognostic information beyond conventional clinical and volumetric assessments.

Main Methods:

  • Retrospective analysis of 156 patients with AHCM without prior AF history who underwent 3.0-T cardiac MRI.
  • Measurement of LAS parameters (reservoir, conduit, booster pump strain) and minimum left atrial volume index (LAVImin).
  • Utilized Cox proportional hazards models and time-dependent ROC analyses to evaluate AF prediction.

Main Results:

  • During a median follow-up of 33 months, 21 patients developed new-onset AF.
  • LAS parameters were independently associated with incident AF in multivariable Cox models (P < .001 for reservoir and booster pump strain, P = .01 for conduit strain).
  • Incorporating LAS into a clinical-volumetric model significantly improved model fit and discrimination (P < .001).

Conclusions:

  • Cardiac MRI-derived LAS is an independent predictor of new-onset AF in AHCM.
  • LAS offers incremental prognostic value beyond routine clinical and left atrial volumetric measures.
  • These findings highlight the potential of LAS as a valuable tool for risk stratification in AHCM patients.

Related Concept Videos

Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...